Why High Hematocrit on TRT Needs More Than Blood Donation
Timeline
Video Summary
A high hematocrit during testosterone therapy requires more context than a blood count alone can provide. Dr. Thomas O’Connor responds to a 55-year-old man reporting a hematocrit of 60.9, hemoglobin of 19.9, decades of testosterone use, and repeated blood donation without consistent iron monitoring.
The discussion centers on androgen-induced erythrocytosis and its relationship to iron balance. As the viewer’s information develops, a ferritin level of 14 is reported, shifting attention toward depleted iron stores despite the elevated blood counts. Dr. O’Connor emphasizes interpreting hemoglobin and hematocrit alongside ferritin and other iron studies rather than assuming that repeated blood removal resolves the underlying problem.
He distinguishes secondary erythrocytosis from polycythemia vera and acknowledges uncertainty about how androgen-related increases in red blood cells translate into clinical outcomes. Possible contributing factors include sensitivity to testosterone, the delivery method, and sleep apnea, while unexplained iron depletion raises a separate question about blood loss.
The conversation then broadens to blood clots, pulmonary embolism, blood pressure, kidney health, glucose control, and cholesterol. These concerns are presented as interacting parts of an individual risk assessment rather than a conclusion drawn from hematocrit alone.
The closing discussion emphasizes working with healthcare providers who understand both androgen exposure and blood disorders. Dr. O’Connor considers changes in testosterone dose or delivery while distinguishing anecdotal observations from established outcome evidence, and he cautions against treating the viewer’s markedly elevated counts as a sustainable situation.
Drug Callouts
Condition Callouts
Key Takeaways
- Elevated hemoglobin and hematocrit should be interpreted alongside ferritin and other iron studies because high blood counts can coexist with depleted iron stores.
- Repeated blood donation does not replace an assessment of why red blood cells are elevated or what is happening to iron stores.
- Androgen-induced erythrocytosis and polycythemia vera have different causes, so an elevated hematocrit alone does not establish the diagnosis.
- Testosterone exposure and reduced oxygen from sleep apnea can both contribute to increased red blood cell production, making additional causes important to investigate.
- Unexplained iron depletion deserves its own evaluation, including consideration of blood loss rather than automatically attributing it to testosterone use.
- Assessing risk requires more than a hematocrit number; blood pressure, kidney health, glucose control, clotting history, and the testosterone regimen also matter.